Registration - In-house Corporation

Vertex Pharmaceuticals (Canada) Incorporated / Michael Siauw, General Manager – Canada

Registration Information

In-house Corporation name: Vertex Pharmaceuticals (Canada) Incorporated
Responsible Officer Name: Michael Siauw, General Manager – Canada
Initial registration start date: 2020-03-18
Registration status: Active
Registration Number: 945696-366162

Associated Communications

Total Number of Communication Reports: 26

Monthly communication reports in the last 6 months: 0

Version 3 of 6 (2021-04-05 to 2021-11-19)

Registration versions:

Version 3 of 6 (2021-04-05 to 2021-11-19)

Lobbying Information

Subject Matters

Economic Development
Health
Intellectual Property
International Trade
Research and Development
Science and Technology
Taxation and Finance

Subject Matter Details

Policies or Program

Common Drug Review, as it relates to health technology assessments and drug product reimbursement recommendations.
Engagement with the Advisory Committee on the Implementation of National Pharmacare and its Secretariat on issues related to access to medicines and rare disorder and orphan drug policies
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals.
Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
Innovation, Science and Economic Development Canada Innovation and Skills Strategy and other government policies and programs related to incentivizing research and development activities in Canada.

Regulation

Proposals to amend guidelines related to the operationalization of the legislation and regulations governing the Patented Medicine Prices Review Board

Communication Techniques

Written communication
Oral communication

Government Institutions

Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Justice Canada (JC)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Senate of Canada

In-house Corporation Details

Description of activities

Vertex is a global biotechnology company that discovers, develops and commercializes innovative medicines. We strive to improve the lives of patients suffering from rare disorders and are currently investing in multiple ongoing research programs targeting serious and life-threatening diseases.

Responsible officer name and position during the period of this registration

Michael Siauw, General Manager – Canada

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
20 Bay Street
unit 1520
Toronto, ON M5J 2N8
Canada

Telephone number: 647-790-1602

Parent Company Information

Vertex Pharmaceuticals Incorporated
- 50 Northern Avenue
  Boston, MA 02210
  United States of America

Subsidiary Beneficiary Information

Vertex Pharmaceuticals (Canada) Incorporated does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Christina Cunningham, Director, Public Affairs | No public offices held
Therese Gagnon-Kugler, Associate Director, Public Affairs | No public offices held
Robert Lee, Associate Director, Public Affairs | No public offices held
Colin Le Fevre, Associate Director, Public Affairs | No public offices held
Michael Siauw, General Manager – Canada | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

No lobbyists added

Vertex Pharmaceuticals (Canada) Incorporated/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Vertex Pharmaceuticals (Canada) Incorporated/	2020-03-18	current

Vertex Pharmaceuticals (Canada) Incorporated

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Michael Siauw, General Manager – Canada (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-26 of 26

Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jed Graham, Policy Advisor | Health Canada (HC)
- Sandenga Yeba, Senior Policy Advisor | Office of the Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development, Science and Technology
Communication date: 2023-07-05
Posted date: 2023-08-15
Communication number: 366162-574953 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Christine Ung, Policy Advisor | Health Canada (HC)
- Josee Leblanc, Senior Policy Advisor | Health Canada (HC)
- Andrew Taylor, Senior Policy Advisor | Health Canada (HC)
- Daniel MacDonald, Director General, Drugs for Rare Diseases | Strategic Policy Branch | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development, Science and Technology
Communication date: 2023-07-04
Posted date: 2023-08-15
Communication number: 366162-574946 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- caroline menard, manager | Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Research and Development, Science and Technology
Communication date: 2023-07-04
Posted date: 2023-08-15
Communication number: 366162-574853 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Denis Arsenault, Manager - Policy Development | Health Canada (HC)
- Emily Griffiths, Subject Matter / Technical Specialist | Health Canada (HC)
- Martin Nemec, Senior Biologist/Evaluator | Health Canada (HC)
- Omar Tounekti, Manager, Gene Therapies Division | Health Canada (HC)
- Aswin Hari, Biologist/Evaluator | Health Canada (HC)
- Michael Rosu-Miles, Director | Health Canada (HC)
Subject Matter of the communication: Health, Research and Development, Science and Technology
Communication date: 2022-08-17
Posted date: 2022-09-09
Communication number: 366162-540988 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Research and Development, Science and Technology
Communication date: 2022-05-31
Posted date: 2022-06-15
Communication number: 366162-533098 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Benoit Leduc, Manager, Life Science Industries Directorate | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Health, Intellectual Property, Research and Development, Science and Technology
Communication date: 2021-12-03
Posted date: 2022-01-05
Communication number: 366162-518729 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Melissa Lantsman, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2021-11-19
Posted date: 2021-12-01
Communication number: 366162-516348 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Adam Vaughan, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2021-06-30
Posted date: 2021-07-28
Communication number: 366162-511846 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michael Cooper, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2021-06-04
Posted date: 2021-07-15
Communication number: 366162-509519 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tom Kmiec, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2021-04-15
Posted date: 2021-05-15
Communication number: 366162-503409 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Alupa A. Clarke, Quebec representative at the Office of the Official Opposition | House of Commons
- Andrew Swidzinski, Advisor, Office of the Official Opposition | House of Commons
Subject Matter of the communication: Health, Intellectual Property, Research and Development
Communication date: 2021-02-22
Posted date: 2021-03-15
Communication number: 366162-496963 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sabina Saini, Chief of Staff | Minister's Office | Health Canada (HC)
- Kathryn Nowers, Director of Policy | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2020-11-13
Posted date: 2020-12-15
Communication number: 366162-488847 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Randeep Sarai, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2020-10-23
Posted date: 2020-11-16
Communication number: 366162-485980 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michael Cooper, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2020-10-13
Posted date: 2020-11-16
Communication number: 366162-485979 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- James Cumming, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2020-10-13
Posted date: 2020-11-16
Communication number: 366162-485978 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Matthew Solheim, Policy Advisor | Office of the Leader of the Opposition | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2020-10-08
Posted date: 2020-11-16
Communication number: 366162-485977 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sean Casey, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2020-09-28
Posted date: 2020-10-15
Communication number: 366162-483240 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Luc Thériault, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2020-09-21
Posted date: 2020-10-15
Communication number: 366162-483239 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Adam Vaughan, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2020-09-16
Posted date: 2020-10-15
Communication number: 366162-483238 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gérard Deltell, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2020-09-14
Posted date: 2020-10-15
Communication number: 366162-483235 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2020-08-12
Posted date: 2020-09-09
Communication number: 366162-481152 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Matt Jeneroux, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2020-08-06
Posted date: 2020-09-09
Communication number: 366162-481153 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- David Yurdiga, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2020-06-26
Posted date: 2020-07-10
Communication number: 366162-476603 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sabina Saini, Chief of Staff | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2020-06-09
Posted date: 2020-07-10
Communication number: 366162-476602 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Elizabeth May, M.P. Saanich - Gulf Islands | Office of Elizabeth May, O.C., M.P. Saanich - Gulf Islands | Bureau de Circonscription, Elizabeth May, Députée Saanich - Gulf Islands | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2020-05-22
Posted date: 2020-06-08
Communication number: 366162-474540 View associated registration
Vertex Pharmaceuticals (Canada) Incorporated
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sabina Saini, Chief of Staff/Chef du Cabinet | Office of the Honourable Patty Hajdu, Minister of Health/Bureau de l’honorable Patty Hajdu, ministre de la Santé | Health Canada (HC)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2020-05-12
Posted date: 2020-06-08
Communication number: 366162-474539 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

Vertex Pharmaceuticals (Canada) Incorporated / Michael Siauw, General Manager – Canada

Registration Information

Associated Communications

Version 3 of 6 (2021-04-05 to 2021-11-19)

Version 3 of 6 (2021-04-05 to 2021-11-19)

Subject Matters

Subject Matter Details

Policies or Program

Regulation

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties